This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5tmg
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
| - | [[Category: Lane, W]] | ||
[[Category: Okada, K]] | [[Category: Okada, K]] | ||
[[Category: Snell, G.P]] | [[Category: Snell, G.P]] | ||
[[Category: Sang, B.C]] | [[Category: Sang, B.C]] | ||
| + | [[Category: Lane, W]] | ||
[[Category: Hideyuki, O]] | [[Category: Hideyuki, O]] | ||
[[Category: Behnke, C.A]] | [[Category: Behnke, C.A]] | ||
Revision as of 13:37, 9 March 2017
Unreleased structure
The entry 5tmg is ON HOLD until Paper Publication
Authors: Snell, G.P., Behnke, C.A., Okada, K., Hideyuki, O., Sang, B.C., Lane, W.
Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor
